Login
$ACRS
$3.79 +$0.04 (1.07%) Close

Company Executives

$ACRS Management Team

Dr. Neal Walker

Non-Executive Chairman of the Board

Chief Executive Officer

Co-Founder

Age 55
Compensation $1.445M USD
Sex Male

Dr. Hugh Davis

President

Chief Operating Officer

Director

Age 66
Compensation $1.595M USD
Sex Male

Mr. Kevin Balthaser

Chief Financial Officer

Age 38
Compensation $1.102M USD
Sex Male

Dr. Roland Kolbeck

Chief Scientific Officer

Age -
Compensation -
Sex Male

Dr. Jesse Hall

Chief Medical Officer

Age -
Compensation -
Sex Male

Mr. James Loerop

Chief Business Officer

Age 61
Compensation $2.333M USD
Sex Male
Directors
8
serving now
Independent
6 of 8
stated in the proxy
Average tenure
8.3 years
from year joined
CEO also chairs the board
Yes
Neal Walker
Director Age On board Independent Committees Other public boards Pay Source
Anand Mehra, M.D.
50 2014
12 years
Independent None stated None stated Not stated
Maxine Gowen, Ph.D.
68 2019
7 years
Independent None stated Passage Bio, Inc. Not stated
Christopher Molineaux
60 2014
12 years
Independent None stated None stated Not stated
Vincent Milano
62 2020
6 years
Independent
Audit · Chair
BioCryst Pharmaceuticals, Inc. Not stated
Hugh Davis, Ph.D.
67 2024
2 years
Not independent None stated None stated Not stated
Neal Walker
56 Not stated Not independent None stated Aldeyra Therapeutics, Inc. Paid as CEO
Andrew Schiff, M.D.
60 2017
9 years
Independent None stated Monte Rosa Therapeutics, Inc. Not stated
William Humphries
59 2016
10 years
Independent None stated Clearside Biomedical, Inc. Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

1 disclosed in the proxy filed Apr 23, 2026
Anand Mehra
a member of our Board
$1.5 million
November 2024

Purchased 666,666 shares of common stock at $2.25 per share in a private placement.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support